옵션 체인은 다양한 행사가격과 만기일에 대한 Nvni Group의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Nvni Group에 대한 시장 심리를 평가합니다..

Nvni Group (NASDAQ:NVNI) 주식, 옵션 체인

Nvni Group

Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.

Nvni Group Ltd

WIIM

UPST

Upstart Holdings shares are trading lower after the company issued Q2 sales guidance below estimates.

Azenta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZTA#NASDAQ">AZTA</a>) reported quarterly earnings of $0.05 per share which missed the analyst consensus estimate of $0.07 by 28.57 percent. This is unchanged from the same period last year. The company reported quarterly sales of $143.00 million which beat the analyst consensus estimate of $140.91 million by 1.48 percent. This is a 10.14 percent decrease over sales of $159.13 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

News

AZTA

Azenta Q2 Adj. EPS $0.05 Misses $0.07 Estimate, Sales $143.00M Beat $140.91M Estimate

SRPT

Sarepta Therapeutics shares are trading lower after the company reported a Q1 adjusted EPS miss.

Telsey Advisory Group analyst Cristina Fernandez maintains Under Armour (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UAA#NYSE">UAA</a>) with a Market Perform and lowers the price target from $10 to $7.

Price Target

Analyst Ratings

Telsey Advisory Group Maintains Market Perform on Under Armour, Lowers Price Target to $7

Kennametal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMT#NYSE">KMT</a>) raises FY2025 Adj EPS guidance from $1.05-$1.30 to $1.30-$1.45 vs $1.13 analyst estimate. Narrows FY2025 sales outlook from $1.95 billion-$2.00 billion to $1.97 billion-$1.99 billion vs $1.97 billion estimate.

Guidance

Kennametal Raises FY2025 Adj EPS Guidance from $1.05-$1.30 to $1.30-$1.45 vs $1.13 Est; Narrows FY2025 Sales Guidance from $1.95B-$2.00B to $1.97B-$1.99B vs $1.97B Est

Blackstone Secured (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BXSL#NYSE">BXSL</a>) reported quarterly earnings of $0.83 per share which beat the analyst consensus estimate of $0.77 by 7.79 percent. This is a 4.6 percent decrease over earnings of $0.87 per share from the same period last year. The company reported quarterly sales of $358.00 million which beat the analyst consensus estimate of $357.54 million by 0.13 percent. This is a 17.78 percent increase over sales of $303.96 million the same period last year.

BXSL

Blackstone Secured Q1 EPS $0.83 Beats $0.77 Estimate, Sales $358.00M Beat $357.54M Estimate

NiSource (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NI#NYSE">NI</a>) reported quarterly earnings of $0.98 per share which beat the analyst consensus estimate of $0.90 by 8.89 percent. This is a 15.29 percent increase over earnings of $0.85 per share from the same period last year.

NiSource Q1 Adj. EPS $0.98 Beats $0.90 Estimate

SMCI

Super Micro Computer shares are trading lower after the company reported worse-than-expected Q3 financial results, issued Q4 guidance below estimates, and cut its FY25 sales guidance.

Perrigo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRGO#NYSE">PRGO</a>) widens FY2025 Adj EPS guidance from $2.90-$3.10 to $2.29-$3.10 vs $2.99 analyst estimate. Widens FY2025 sales outlook from $4.42 billion-$4.50 billion to $4.37 billion-$4.50 billion vs $4.44 billion estimate.

PRGO

Perrigo Widens FY2025 Adj EPS Guidance from $2.90-$3.10 to $2.29-$3.10 vs $2.99 Est; Widens FY2025 Sales Guidance from $4.42B-$4.50B to $4.37B-$4.50B vs $4.44B Est

ELAN

Elanco Animal Health Sees FY25 Adj EPS Of $0.80 - $0.86 Vs. $0.820 Est.

Bio-Techne also announced this week that its board of directors has approved a new share repurchase program authorizing the repurchase of up to $500 million of common stock. The new share repurchase program begins May 8, 2025 and replaces the previous program. The timing and number of shares to be repurchased will depend on factors such as the share price, economic and market conditions, and corporate and regulatory requirements. The share repurchase program may be suspended, amended, or discontinued at any time and does not obligate the Company to acquire any specific dollar amount or number of shares of common stock.

Buybacks

TECH

Bio-Techne Board Approves New Stock Buyback Of $500M

Telsey Advisory Group analyst Cristina Fernandez maintains On Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONON#NYSE">ONON</a>) with a Outperform and lowers the price target from $67 to $65.

ONON

Telsey Advisory Group Maintains Outperform on On Holding, Lowers Price Target to $65

Arq (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARQ#NASDAQ">ARQ</a>) reported quarterly sales of $27.25 million which beat the analyst consensus estimate of $26.27 million by 3.73 percent. This is a 25.33 percent increase over sales of $21.74 million the same period last year.

Arq Q1 Sales $27.25M Beat $26.27M Estimate; Net Income $0.2M Up From Net loss ($3.4)M YoY

Turning Point Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPB#NYSE">TPB</a>) reported quarterly earnings of $0.91 per share which beat the analyst consensus estimate of $0.78 by 16.67 percent. This is a 13.75 percent increase over earnings of $0.80 per share from the same period last year. The company reported quarterly sales of $106.44 million which beat the analyst consensus estimate of $95.75 million by 11.16 percent. This is a 9.66 percent increase over sales of $97.06 million the same period last year.

Turning Point Brands Q1 Adj. EPS $0.91 Beats $0.78 Estimate, Sales $106.44M Beat $95.75M Estimate

Valens Semiconductor Q1 Adj. EPS $(0.03), Inline, Sales $16.83M Beat $16.48M Estimate

RXO (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RXO#NYSE">RXO</a>) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $(0.02) by 50 percent. This is unchanged from the same period last year. The company reported quarterly sales of $1.43 billion which missed the analyst consensus estimate of $1.49 billion by 4.06 percent. This is a 56.96 percent increase over sales of $913.00 million the same period last year.

RXO Q1 Adj. EPS $(0.03) Misses $(0.02) Estimate, Sales $1.43B Miss $1.49B Estimate

Kennametal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMT#NYSE">KMT</a>) reported quarterly earnings of $0.47 per share which beat the analyst consensus estimate of $0.24 by 95.83 percent. This is a 56.67 percent increase over earnings of $0.30 per share from the same period last year. The company reported quarterly sales of $486.40 million which missed the analyst consensus estimate of $490.42 million by 0.82 percent. This is a 5.70 percent decrease over sales of $515.79 million the same period last year.

Kennametal Q3 Adj. EPS $0.47 Beats $0.24 Estimate, Sales $486.40M Miss $490.42M Estimate

Elanco Animal Health Raises FY25 Revenue Guidance From $4.445B - $4.510B To $4.510B - $4.580B Vs. $4.484B Est.

Cencora Q2 Adj. EPS $4.42 Beats $4.11 Estimate, Sales $75.45B Miss $75.68B Estimate

Perrigo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRGO#NYSE">PRGO</a>) reported quarterly earnings of $0.60 per share which beat the analyst consensus estimate of $0.55 by 9.09 percent. This is a 106.9 percent increase over earnings of $0.29 per share from the same period last year. The company reported quarterly sales of $1.04 billion which missed the analyst consensus estimate of $1.09 billion by 3.92 percent. This is a 3.51 percent decrease over sales of $1.08 billion the same period last year.

Comments

Nvni Group

Nvni Group (NVNI) 옵션

No option chain data available. Please try again later

뉴스

파트너 / 기고자

벤징가 글로벌